Source: Eur Respir J, 53 (5) 1802220; 10.1183/13993003.02220-2018
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Roberto F. Casal, Boris Sepesi, Ala-Eddin S. Sagar, Juerg Tschirren, Minxing Chen, Liang Li, Jennifer Sunny, Joyce Williams, Horiana B. Grosu, George A. Eapen, Carlos A. Jimenez, David E. Ost. Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software. Eur Respir J, 53 (5) 1802220; 10.1183/13993003.02220-2018

Member's Comments

No comment yet.

Related content which might interest you: Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002 Probability of malignancy based on automatic segmentation and software measurements of nodules in the Danish lung cancer screening trial (DLCST) Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019 Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines Source: Annual Congress 2010 - State of the art imaging Year: 2010 Incidence of hidden extrathoracic metastases and unexpected second malignancies detected by PET in patients with lung cancer. Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Complete and systematic mediastinal nodal staging for lung cancer (SCORE study)> Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules Year: 2018 Detection of unusual distant metastases or secondary malignancies in the routine staging of primary lung cancer with 18F-FDG-PET/CT Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005 An algorithm for lung cancer staging Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer Year: 2014 Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening Source: Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020 Year: 2021 Lung metastasectomy should always be performed. The aim of new dedicated TNM staging for lung metastases Source: Virtual Congress 2021 – Lung metastasectomy: let’s pour some water on the fire Year: 2021 Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity? Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019